Healthcare - Biotechnology - NASDAQ - US
$ 0.3208
-11.5 %
$ 62.2 M
Market Cap
-0.15
P/E
CASH FLOW STATEMENT
-235 M
OPERATING CASH FLOW
155 M
INVESTING CASH FLOW
196 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
bluebird bio, Inc.
| Net Income | -212 M |
| Depreciation & Amortization | 28.5 M |
| Capital Expenditures | -9.06 M |
| Stock-Based Compensation | 19.4 M |
| Change in Working Capital | -49.7 M |
| Others | -89.3 M |
| Free Cash Flow | -244 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | (211.9) | (266.6) | (819.4) | (618.7) | (789.6) | (555.6) | (335.6) | (263.5) | (166.8) | (48.7) | (25.3) | (23.7) | (15.6) |
| Depreciation & Amortization | 28.5 | 5.0 | 19.6 | 19.4 | 17.4 | 17.2 | 13.5 | 9.6 | 7.4 | 4.2 | 0.9 | 0.3 | 0.2 |
| Deferred Income Tax | 0 | 0 | 0.6 | 7.2 | 9.3 | (2.2) | 0 | 0 | 0 | (11.8) | 0 | 0 | 0 |
| Stock Based Compensation | 19.4 | 35.2 | 127.9 | 156.6 | 160.6 | 110.8 | 53.3 | 39.8 | 41.1 | 10.8 | 6.5 | 0.8 | 0.9 |
| Other Operating Activities | (21.4) | (87.4) | 17.6 | (6.0) | (8.3) | (2.9) | 1.0 | 5.5 | 3.9 | 0.6 | 0.4 | 18 K | 0.4 |
| Change in Working Capital | (49.7) | (39.1) | 18.0 | (28.9) | 46.1 | 19.2 | (12.7) | 19.0 | 16.0 | (14.7) | 60.9 | 1.5 | 1.9 |
| Cash From Operations | (235.0) | (353.0) | (635.6) | (470.4) | (564.4) | (413.4) | (280.6) | (189.6) | (98.4) | (59.7) | 43.5 | (21.0) | (12.2) |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | (9.1) | (13.2) | (23.0) | (29.0) | (76.3) | (55.7) | (62.2) | (16.0) | (7.1) | (8.7) | (8.7) | (0.9) | (0.4) |
| Other Items | 164.0 | 263.7 | 585.6 | (55.4) | 584.1 | (623.7) | (253.8) | 78.7 | (564.8) | (148.5) | (1.2) | 3.5 | (3.6) |
| Cash From Investing Activities | 154.9 | 250.5 | 562.6 | (84.3) | 507.8 | (679.4) | (316.0) | 62.7 | (571.9) | (157.2) | (9.8) | 2.6 | (4.0) |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (54.4) | (36.7) | 0 | 0 | 0 | 2.1 | 37.4 | 1.7 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.4 | 16 K | (168.9) | 5.2 | 21.2 | 735.6 | 1 038.7 | 4.9 | (0.5) | 0 | 0.3 | 59.9 | 32.4 |
| Cash From Financing Activities | 196.2 | 54.3 | (94.0) | 546.7 | 21.2 | 737.7 | 1 076.2 | 241.5 | 486.7 | 358.5 | 105.6 | 59.9 | 32.4 |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | 116.2 | (48.2) | (167.0) | (8.0) | (35.4) | (355.2) | 479.6 | 114.6 | (183.6) | 141.6 | 139.3 | 41.4 | 16.3 |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | (244.1) | (366.2) | (658.6) | (499.3) | (640.6) | (469.2) | (342.8) | (205.6) | (105.5) | (68.4) | 34.8 | (21.9) | (12.6) |